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BACKGROUND AND PURPOSE: Stent placement may be an effective and last resort method for
recanalization of recalcitrant intracranial artery occlusion. The purpose of this study was to evaluate the
safety and efficacy of a self-expanding stent for the recanalization of acute embolic or dissecting
intracranial artery occlusion.
MATERIALS AND METHODS: Nine patients (mean age, 66 years; NIHSS score, 10–23) with acute
embolic (n  8) or dissecting occlusion (n  1) of the intracranial arteries (ICA terminus in 5, MCA in
3, and BA in 1) were treated with a recapturable self-expanding stent. The safety and efficacy of the
stent for recanalization were evaluated retrospectively.
RESULTS: The emboli were entrapped against the vessel wall by the stent, resulting in immediate
recanalization (TIMI 2) in all embolic occlusions. The dissecting occlusion was recanalized completely
(TIMI 3). Adjunctive thrombolytics (n  8, urokinase, 100,000–300,000 U) and/or GP IIb/IIIa antagonist
(n  7, tirofiban, 0.5–1 mg) were administered intra-arterially, and the degree of recanalization further
improved in 4 embolic occlusions (TIMI 3). Acute in-stent thrombosis occurred in 2 patients, who
received only urokinase without GP IIb/IIIa antagonist. Both of the reoccluded arteries were reopened,
by stent recapture in 1 and by intra-arterial administration of GP IIb/IIIa antagonist in the other.
Recapture was attempted in 7 cases, of which there were 3 successful outcomes. There was 1
asymptomatic hemorrhagic conversion at the infarction site. The mean improvement of the NIHSS
score between baseline and discharge was 12.3 (range, 3–22).
CONCLUSIONS: Preliminary results of this study suggest that a self-expanding stent may be safe and
efficient for recanalization of acute embolic or dissecting intracranial artery occlusion.
ABBREVIATIONS: ACA  anterior cerebral artery; BA  basilar artery; Fx  fracture; GP  glyco-
protein; hrs  hours; ICA  internal carotid artery; IV  intravenous; M1 MCA M1 portion; M2 
MCA M2 portion; MCA  middle cerebral artery; NIHSS  National Institutes of Health Stroke
Scale; PCA  posterior cerebral artery; rtPA  recombinant tissue plasminogen activator; TIMI 
Thrombolysis In Myocardial Ischemia; Tx  treatment; UK  urokinase
Stent placement may be an effective and last resort methodfor recanalization of recalcitrant intracranial artery occlu-
sion with a published recanalization rate between 79% and
89%.1-3 However, balloon-expandable stents are difficult to
navigate through an intracranial artery and carry inherent
risks associated with balloon inflation for stent deployment.
Also, tortuosity and the difference in diameters of the parent
artery proximal and distal to the occlusion site may make it
difficult to apply balloon-expandable stents to the recanaliza-
tion of an acutely occluded intracranial artery. Recently, there
were 2 reports regarding the use and efficacy of the self-ex-
panding stent for the recanalization of acute intracranial ar-
tery occlusion.2,3 Also, 2 recent case reports described an in-
novative temporary endovascular bypass method for
recanalization by using a newly developed Enterprise recap-
turable self-expanding stent (Cordis,Miami Lakes, Florida).4,5
However, little is known about the feasibility, safety, efficacy,
and recapturability of the newly developed Enterprise stent for
recanalization in acute strokes. In this case series, we present
our experience in applying Enterprise stents to the recanaliza-
tion of major intracranial arteries with acute embolic or dis-
secting occlusion.
Materials and Methods
The institutional review board approved this retrospective study. Pa-
tient informed consent for study inclusion was waived, though pa-
tient informed consent for pharmacologic or mechanical thrombo-
lytic treatment, including angioplasty and/or stent placement, was
obtained from the patients’ legal representatives. Nine patients (mean
age, 66 years; NIHSS score, 10–23) with acute embolic (n  8) or
dissecting (n 1) occlusion of intracranial arteries were treated with
Enterprise stents between November 2008 and April 2009. The pa-
tients had experienced an acute stroke within 12 hours of the symp-
tom onset (range, 1.5–12 hours; mean, 5.3 hours) and had a baseline
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NIHSS score of 10 (range, 10–23; mean, 17). There was no intra-
cranial hemorrhage or clear early cerebral infarction that was more
than or equal to one-third of the vessel distribution on the pretreat-
ment CT and/orMR imaging. Acute occlusion of amajor intracranial
arterywas identified on the pretreatmentCTorMRangiography. The
cause of the occlusion was judged according to pre-existing medical
conditions and angiographic findings (On-line Table). IV adminis-
tration of rtPA was not indicated because of the limited time window
(3 hours after symptom onset), age older than 80 years, recent car-
diac surgery, and/or traumatic arterial dissection, except in 1 patient
who received a bridging dose of rtPA (0.5 mg/kg) (On-line Table).
The degree of recanalization was assessed by a neuroradiologist who
did not participate in the treatment, in accordance with the TIMI
grading system. Early clinical outcomes were evaluated according to
the NIHSS score 24 hours after treatment and again at discharge.
Routine 3- or 4-vessel cerebral angiography was first performed
before treatment. After the occlusion site of a major intracranial ar-
tery was identified, a 6F guiding catheter (Envoy, Cordis; or Shuttle,
Cook, Bloomington, Indiana) was placed at the distal cervical portion
of the relevant ICA or vertebral artery. After the placement of the
guiding catheter, a 3000-unit IV heparin bolus was injected, followed
by a 1000-unit/h IV infusion. Enterprise stent placement was the ini-
tial mechanical maneuver for the recanalization of acutely occluded
vessels. The lesion length was estimated as the distance between the
vessel cutoff on the baseline conventional angiography and the begin-
ning of the normal vessel distal to the clot on the microcatheter an-
giography. A Prowler Select Plus microcatheter (Cordis) was navi-
gated to a branch of the distal normal portion of the artery by using a
0.014-inch guidewire. Then an Enterprise stent was introduced and
deployed, spanning the entire obstructive segment.
Enterprise stents were first partially deployed in 7 patients for
possible recapture after recanalization. In the other 2 patients, Enter-
prise stents were fully deployed due to traumatic arterial dissection in
1 and for a second stent placementwith a Y-configuration at theMCA
bifurcation in the other. Immediately after stent deployment, 100,000
U of urokinase and a bolus of GP IIb/IIIa antagonist (tirofiban, 0.5–1
mg) were loaded intra-arterially in 6 patients. Of the remaining 3
patients, 1 received GP IIb/IIIa antagonist (tirofiban, 0.5 mg) and the
other 2 received 200,000 and 300,000U of urokinase, respectively. GP
IIb/IIIa antagonist was administrated due to the lack of antiplatelet
premedication, and urokinase was infused for dissolving the embolus
entrapped by the stent. In the patients with permanent stent place-
ment, IV infusion of GP IIb/IIIa antagonist (tirofiban) was main-
tained for 24–36 hours after the completion of the procedure. In
addition, a loading dose of dual antiplateletmedication (aspirin, 100–
500 mg, plus clopidogrel, 300 mg) was immediately administered
through an orally placed gastric tube or just orally, after the proce-
dure. The maintenance of the dual antiplatelet medication dose was
followed thereafter.
Results
The baseline clinical data, intervention, and early clinical and
angiographic outcomes are all summarized in the On-line Ta-
ble. Four patients had acute occlusion from the ICA terminus
to both the proximal MCA and the ACA, 1 had an acute oc-
clusion from the ICA terminus to the proximal MCA M1, 2
had acute occlusions fromMCAM1 to the M2 portion, 1 had
an acute occlusion at the MCA M1 portion, and 1 had acute
occlusion from the distal BA to the bilateral PCAs. Seven pa-
tients had atrial fibrillation and revealed an abrupt cutoff from
the normal-calibered artery on the angiogram. Therefore, the
cause of acute arterial occlusionwas judged to be a cardiogenic
embolism.One patient had been admitted due to head trauma
2 days before the symptom onset and had a fracture of the
ipsilateral optic strut adjacent to the occlusion site of the ICA;
therefore, the cause of the occlusion was judged to be arterial
dissection. The remaining patient had concomitant acute tan-
dem occlusion of the ipsilateral cervical ICA bulb and MCA;
therefore, the cause of theMCA occlusion was judged to be an
artery-to-artery embolism.
The emboli were entrapped against the vessel wall by the
Enterprise stent, resulting in immediate recanalization (TIMI
2) in all 8 embolic occlusions (Fig 1). The ICA dissecting oc-
clusion was completely recanalized (TIMI, 3). After an ad-
junctive thrombolytic or a bolus of intra-arterial GP IIb/IIIa
inhibitor, or both were administered, the degrees of recanali-
zation were further improved to TIMI 3 in 4 embolic occlu-
sions. In 2 of the remaining 4 embolic occlusions, the degree of
recanalization was also improved but did not reach TIMI 3.
The last 2 patients, who only received urokinase without the
GP IIb/IIIa antagonist, revealed acute in-stent thrombosis
10–20 minutes after initial recanalization. Both of the re-oc-
cluded arteries in those 2 patients were reopened by recapture
of the stent in 1 and by intra-arterial administration of GP
IIb/IIIa antagonist (Fig 2) in the other.
Recapture was attempted in 7 patients in whom Enterprise
stents were partially deployed. Recaptures were not attempted
until the entrapped emboli were sufficiently resolved on the
angiogram in 6, with the exception of 1 patient in whom re-
capture was attempted due to acute in-stent occlusion. There-
fore, the period between the initial partial deployment and the
attempt to recapture varied from 15 to 180minutes, according
to the embolus burden. Recapture was successful in 3 patients
in whom it was attempted within 30 minutes after partial de-
ployment of the stent, whereas in the other 4 patients with
recapture failure, it was attempted in 120 minutes. There
was only 1 small asymptomatic hemorrhagic conversion of the
infarction site of the basal ganglia in a patient with traumatic
ICA dissection. Mean improvement of the NIHSS score be-
tween the baseline and discharge was 12.3 (range, 3–22).
Short-term follow-up vascular imaging (conventional angiog-
raphy in 5 and CT and/or MR angiography in 4), which was
available 3 days to 2 weeks after treatment, revealed persistent
patency of the arteries in all patients and full expansion of the
stent in the 6 patients who had undergone permanent stent
placement (Fig 1).
Discussion
A recapturable self-expanding stent can be used as either a
permanent stent placement or an endovascular temporary by-
pass method to entrap thrombus against the vessel wall for
recanalization in the acute occlusion setting of a major intra-
cranial artery.4-7 This strategy of using a recapturable self-ex-
panding stent may provide immediate recanalization of an
acutely occluded artery. This early restoration of flow may
more quickly promote endogenous or pharmacologic throm-
bolysis. If blood flow through the occlusion site is restored, as
seen in patients in this series, the thrombus entrapped by the
stent may dissolve due to the GP IIb/IIIa antagonist and/or a
small amount of thrombolytics. Furthermore, once reperfu-
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sion to the ischemic brain tissue is restored, it allows us
enough time to preclude or to minimize the dose of thrombo-
lytics to completely dissolve the remaining entrapped throm-
bus. A mean of 150,000 U (range, 100,000–300,000 U) of
urokinase was used in 8 of 9 patients, which was a very small
amount, considering the large amount of thrombus burden at
the ICA terminus or proximalMCA.Moreover, in the remain-
ing patient, only GP IIb/IIIa antagonist without thrombolytics
was sufficient to prevent reocclusion and to dissolve the en-
trapped thrombus.
In the cardioembolic occlusion at the ICA terminus, recan-
alization is very difficult with intra-arterial strategies as well as
IV rtPA because of the large amount of thrombus burden. The
causes of the 5 ICA terminus occlusions included in our series
consisted of 4 cardiogenic embolisms and 1 traumatic dissec-
tion. In all 4 cases of cardioembolic occlusion from the ICA
terminus extending to both the proximal MCA and ACA, im-
mediate recanalization could be achieved by partial deploy-
ment of the stent, despite a large amount of embolus burden.
This immediate recanalizationmay be themost important ad-
vantage of the stent placement in acute stroke. Another possi-
ble advantage of the stent strategy for recanalization is to pro-
hibit distal migration of the embolus. In our experience, distal
migration of the embolus was frequently observed as the em-
bolus dissolved and became smaller during intra-arterial
thrombolysis with rtPA or urokinase; one example was the
migration of the embolus from the ICA to the MCA. When
applying mechanical thrombolysis by using a microwire or
balloon, we also frequently observed distal migration/emboli-
zation of the embolus or macerated clots. Although the mac-
erated emboli were relatively easily dissolved by thrombolytics
or endogenously, it was sometimes problematic in that those
emboli frequently occluded the arterial branches supplying
the eloquent area of the brain. On the other hand, complete or
partial deployment of a self-expanding stent spanning the en-
tire embolus is less likely to cause distal migration or emboli-
zation of the embolus. In our patients, there was no distal
migration or embolization of the entrapped embolus visible
on the angiogram.
Onemay be concerned that a self-expanding stent may not
have sufficient radial force to recanalize the occluded artery.
However, initial recanalization was successful in all of our pa-
tients, including cardioembolic (n  7), artery-to-artery em-
bolic (n 1), and arterial dissection (n 1). This suggests that
a self-expanding stent with low radial force may be sufficient
to entrap the embolus against the vessel wall, causing imme-
diate recanalization of acute embolic or dissecting occlusion.
There were only 2 case series regarding the use of self-ex-
panding stents for recanalization in acute stroke in the existing
literature, in which recanalization rates with self-expanding
stents were 79% and 89%, respectively. 2,3 In the experimental
embolism model, the TIMI 2/3 recanalization rate with self-
expanding stents was 91%.8 Although it is impossible to di-
rectly compare our results and those of the previous 2 case
series because of the small number of patients, we guess that
the case selection may affect the rate of recanalization. In our
patients, the cause of acute arterial occlusion was not arterio-
sclerotic stenosis but rather obviously emboli or dissection. In
the previous 2 series, the causes of acute occlusion were not
mentioned; therefore, those cases might have included arte-
Fig 1. Case 1. A 44-year-old woman who presented with
acute stroke and an NIHSS score of 22. A, Left internal
carotid angiogram in the lateral projection shows acute
cutoff just above the takeoff of the posterior communicating
artery. B, Partial deployment of the Enterprise stent. Note the
distal markers of the stent (white arrow) and the distal
marker of the Prowler Select Plus microcatheter (black ar-
row). C, Three-hour delay angiogram in the lateral projection
after the intra-arterial administration of urokinase (100,000
U), and tirofiban (0.5 mg), reveals a TIMI 3 recanalization.
Note a notch (arrow) in the stent corresponding to the portion
in which thrombus is entrapped between the stent and the
arterial wall. D, Follow-up angiogram 1 week after thrombol-
ysis reveals the full expansion of the previously noted notch
in the stent and normal flow from the ICA to the MCA and
ACA.
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riosclerotic in situ occlusion at the pre-existing stenotic por-
tion of the artery. In our opinion, a self-expanding stent may
be less likely to be effective in the recanalization of acute arte-
riosclerotic in situ occlusionwith pre-existing stenosis because
of its low radial force.
Recapturability of the Enterprise stent is an important ad-
vantage in its use for recanalization of acute strokes. As men-
tioned in 2 innovative case reports, the recapture of the stent
after thrombolysis has several possible advantages over per-
manent stent placement.4,5 In our case series, however, recap-
ture was successful in 3 of the 7 attempted cases. One possible
explanation is the difference in time from deployment to at-
tempt to recapture between the successful and the failed cases.
In the 4 failed cases, the time was 120 minutes whereas the
duration of our 3 successful procedures and the other 2 re-
ported procedures4,5 was30minutes. The longer the stent is
partially deployed, the greater is the possibility of microclot
deposition within the stent-delivery catheter. This may in-
crease friction and difficulty during the recapture of the stent.
In the acute phase of a stroke, 1 of the major concerns regard-
ing the use of the stent is in-stent thrombosis due to the lack of
antiplatelet premedication. In our series, in-stent thrombosis
occurred in 2 patients, both of whom received only urokinase,
not the GP IIb/IIIa antagonist. This suggests that the GP IIb/
Fig 2. Case 6. A 74-year-old woman presenting with a stuporous mental state. A, Right vertebral artery angiogram reveals
embolic occlusion of the BA terminus. B, Immediately after the partial deployment of an Enterprise stent, a TIMI 2
recanalization is achieved. Note the distal markers of the partially deployed stent (arrow). C, On an angiogram 10 minutes
after the adjunctive intra-arterial administration of urokinase (100,000 U), in-stent reocclusion occurs. D, Although thrombus
removal is attempted by the recapture of the stent, persistent reocclusion is noted. E, TIMI 2 recanalization (arrow)
immediately after the second partial deployment of the stent. F, Intra-arterial administration of the GP IIb/IIIa antagonist
(tirofiban, 1 mg) improves the recanalization state, and the stent is retrieved (not shown). The final angiogram after recapture
of the stent shows complete recanalization from the BA to the right PCA, but the occlusion of the left PCA still remains. G,
Follow-up MR angiogram reveals complete recanalization from the BA to the bilateral PCAs.
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IIIa antagonist may be essential in stent placement for the
recanalization of an acute stroke with lack of antiplatelet pre-
medication. Another major concern is the possibility of in-
creased risk of fatal intracranial hemorrhage associated with
procedural and/or postprocedural antiplatelet medication.
Although only a small number of patients were included, there
was no symptomatic intracranial hemorrhage in our series.
The possible risk and efficacy of self-expanding stents for the
recanalization of recalcitrant intracranial artery occlusion
warrants further study.
Conclusions
Although a small number of patients were included in this
study, preliminary results of this case series suggest that a self-
expanding stent may be a safe and efficient tool for recanali-
zation of acute embolic or dissecting intracranial artery occlu-
sion. These preliminary results may warrant further study
regarding the application of this type of stent to acute embolic
or dissecting intracranial artery occlusion within a larger
population.
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